These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Updated, web-based nutrition management guideline for PKU: An evidence and consensus based approach. Singh RH; Cunningham AC; Mofidi S; Douglas TD; Frazier DM; Hook DG; Jeffers L; McCune H; Moseley KD; Ogata B; Pendyal S; Skrabal J; Splett PL; Stembridge A; Wessel A; Rohr F Mol Genet Metab; 2016 Jun; 118(2):72-83. PubMed ID: 27211276 [TBL] [Abstract][Full Text] [Related]
3. Similarities and differences in key diagnosis, treatment, and management approaches for PAH deficiency in the United States and Europe. Lowe TB; DeLuca J; Arnold GL Orphanet J Rare Dis; 2020 Sep; 15(1):266. PubMed ID: 32977849 [TBL] [Abstract][Full Text] [Related]
4. Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians' current practices. Yuskiv N; Potter BK; Stockler S; Ueda K; Giezen A; Cheng B; Langley E; Ratko S; Austin V; Chapman M; Chakraborty P; Collet JP; Pender A; Orphanet J Rare Dis; 2019 Jan; 14(1):7. PubMed ID: 30621767 [TBL] [Abstract][Full Text] [Related]
10. Phenylalanine hydroxylase deficiency treatment and management: A systematic evidence review of the American College of Medical Genetics and Genomics (ACMG). Adams AD; Fiesco-Roa MÓ; Wong L; Jenkins GP; Malinowski J; Demarest OM; Rothberg PG; Hobert JA; Genet Med; 2023 Sep; 25(9):100358. PubMed ID: 37470789 [TBL] [Abstract][Full Text] [Related]
11. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics. Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647 [TBL] [Abstract][Full Text] [Related]
12. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
13. Diseases of phenylalanine metabolism. Parker CE West J Med; 1979 Oct; 131(4):285-97. PubMed ID: 388868 [TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
18. Phenylalanine hydroxylase mutations and phenylalanine-tyrosine metabolism in heterozygotes for phenylalanine hydroxylase deficiency. Verduci E; Riva E; Agostoni C; Leviti S; Fiori L; Lammardo AM; Biondi ML; Giovannini M Acta Paediatr; 2002; 91(7):805-10. PubMed ID: 12200907 [TBL] [Abstract][Full Text] [Related]
19. National Institutes of Health (NIH) review of evidence in phenylalanine hydroxylase deficiency (phenylketonuria) and recommendations/guidelines for therapy from the American College of Medical Genetics (ACMG) and Genetics Metabolic Dietitians International (GMDI). Greene CL; Longo N Mol Genet Metab; 2014 Jun; 112(2):85-6. PubMed ID: 24745849 [No Abstract] [Full Text] [Related]
20. Management of Women With Phenylalanine Hydroxylase Deficiency (Phenylketonuria): ACOG Committee Opinion Summary, Number 802. Obstet Gynecol; 2020 Apr; 135(4):987-988. PubMed ID: 32217972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]